CAMBRIDGE, England–(BUSINESS WIRE)–Today, Amgen announced that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for TEPEZZA® (teprotumumab) as the first therapy specifically licensed for the trea…
Category: Business
Alcon Announces Results of 2025 Annual General Meeting
GENEVA–(BUSINESS WIRE)–Alcon Announces Results of 2025 Annual General Meeting
Alcon Announces Results of 2025 Annual General Meeting
GENEVA–(BUSINESS WIRE)–Alcon Announces Results of 2025 Annual General Meeting
Breakthrough Gene Therapies Poised to Transform Cone Rod Dystrophy Treatment Landscape – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Cone Rod Dystrophy Market: Analysis By Type, By Treatment Type, By End User, By Region Size and Trends – Forecast up to 2030” has been added to ResearchAndMarkets.com’s offering. As of 2024, the global cone rod dystrophy m…
OcuSciences Announces FDA Marketing Clearance of OcuMet Beacon in Retinal Health Assessment at ARVO
ANN ARBOR, Mich.–(BUSINESS WIRE)–OcuSciences, Inc., a leader in advanced ocular diagnostics, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for its flagship device, the OcuMet Beacon, proprietary, non-invasive …
Glaukos Announces First Quarter 2025 Financial Results
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financ…
Bausch + Lomb Announces First-Quarter 2025 Results
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its first-quarter 2025 financial results. “Our core business is pe…
Bausch + Lomb Announces First-Quarter 2025 Results
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its first-quarter 2025 financial results. “Our core business is pe…
Azalea Vision raccoglie 9 milioni di euro nella prima conclusione di un finanziamento di Serie A per promuovere lo sviluppo di una piattaforma di visione intelligente connessa
GHENT, Belgio–(BUSINESS WIRE)–Azalea (A-zuh-lay-ah) Vision, azienda di HealthTech (tecnologia sanitaria) che progetta il futuro della vista, oggi ha annunciato la prima conclusione del suo round di finanziamento di Serie A da 15 milioni di euro, racc…
Azalea Vision raccoglie 9 milioni di euro nella prima conclusione di un finanziamento di Serie A per promuovere lo sviluppo di una piattaforma di visione intelligente connessa
GHENT, Belgio–(BUSINESS WIRE)–Azalea (A-zuh-lay-ah) Vision, azienda di HealthTech (tecnologia sanitaria) che progetta il futuro della vista, oggi ha annunciato la prima conclusione del suo round di finanziamento di Serie A da 15 milioni di euro, racc…
アザレア・ビジョン、シリーズAラウンドの初回クロージングで900万ユーロを調達し、インテリジェントなコネクテッド・ビジョン・プラットフォームの開発をさらに推進
ベルギー・ゲント–(BUSINESS WIRE)–（ビジネスワイヤ） — 視覚の未来を作るヘルステック企業のアザレア・ビジョンは、1,500万ユーロのシリーズA資金調達ラウンドの初回クロージングで、900万ユーロを調達したことを発表しました。併せて、ロバート・J・デンプシーが取締役会会長に就任し、欧州および米国市場での戦略的成功を指揮することも発表しました。 アザレア・ビジョンのCEOであるエンリケ・ベガは次のように述べています。「今回のシリーズAのマイルストーンにおいてリピート投資家が積極的…
Azalea Vision完成A轮融资首次交割，募集900万欧元以进一步开发智能互联视觉平台
比利时根特–(BUSINESS WIRE)–(美国商业资讯)– 致力于开创视力未来的医疗科技公司Azalea (A-zuh-lay-ah) Vision今日宣布，其1500万欧元A轮融资已完成首次交割，成功募集900万欧元。同时，公司任命Robert J. Dempsey为董事会主席，以指导公司在欧洲和美国市场的战略发展。 Azalea Vision首席执行官Enrique Vega表示：“在这一A轮融资里程碑中，老投资者的踊跃参与再次证明了他们对我们的医疗器械以及为推动智能眼部健康未来所开展…
Azalea Vision lève 9 millions EUR dans le cadre de la clôture de la première phase d’un financement de série A pour poursuivre le développement de sa plateforme intelligente de vision connectée
GAND, Belgique–(BUSINESS WIRE)–Azalea (A-zuh-lay-ah) Vision, une société de heathtech qui conçoit l’avenir de la vue, vient d’annoncer aujourd’hui la clôture de la première phase de son cycle de financement de série A de 15 millions EUR, dans le cadr…
Azalea Vision recauda 9 millones de euros en el primer cierre de su ronda de Serie A para impulsar su plataforma de visión conectada inteligente
GHENT, Bélgica–(BUSINESS WIRE)–Azalea (A-zuh-lay-ah) Vision, empresa de tecnología sanitaria (HealthTech) que diseña el futuro de la visión, acaba de anunciar el primer cierre de su ronda de financiación de Serie A de 15 millones de euros, con la que…
Samenvatting: Azalea Vision haalt €9 miljoen op in de eerste afsluiting van een Serie A-financieringsronde om het Intelligent Connected Vision Platform verder te ontwikkelen
GENT, België–(BUSINESS WIRE)–Azalea (A-zuh-lay-ah) Vision, een HealthTech-bedrijf dat de toekomst van het zichtvermogen vorm geeft, kondigde vandaag de eerste afsluiting van haar Serie A-financieringsronde van €15 miljoen aan, waarbij €9 miljoen werd…
Azalea Vision arrecada 9 milhões de euros na primeira fase de financiamento de Série A para continuar desenvolvendo sua plataforma de visão inteligente conectada
GHENT, Bélgica–(BUSINESS WIRE)–A Azalea (A-zuh-lay-ah) Vision, uma empresa de tecnologia da saúde que está projetando o futuro da visão, anunciou hoje o primeiro fechamento de sua rodada de financiamento de Série A no valor de 15 milhões de euros, ar…
Azalea Vision完成A輪融資首次交割，籌集900萬歐元以進一步開發智慧互聯視覺平台
比利時根特–(BUSINESS WIRE)–(美國商業資訊)– 致力於開創視力未來的醫療科技公司Azalea (A-zuh-lay-ah) Vision今日宣布，其1500萬歐元A輪融資已完成首次交割，成功籌集900萬歐元。同時，公司任命Robert J. Dempsey為董事長，以指導公司在歐洲和美國市場的策略發展。 Azalea Vision執行長Enrique Vega表示：「在這一A輪融資里程碑中，重複投資人的踴躍參與再次證明了他們對我們的醫療器材以及為推動智慧眼部健康未來所展開創新的…
Azalea Vision sammelt 9 Millionen Euro in erster Finanzierungsrunde der Serie A zur Weiterentwicklung seiner intelligenten vernetzten Bildverarbeitungsplattform
GHENT, Belgien–(BUSINESS WIRE)–Azalea (A-zuh-lay-ah) Vision, ein HealthTech-Unternehmen, das die Zukunft des Sehens gestaltet, gab heute den ersten Abschluss seiner Serie-A-Finanzierungsrunde in Höhe von 15 Millionen Euro bekannt. Dabei wurden 9 Mill…
Luxa to Present Phase 1/2a Clinical and Preclinical Data on RPESC-RPE-4W Therapy for Dry AMD at 2025 ARVO Annual Meeting
FORT LEE, N.J.–(BUSINESS WIRE)–Luxa Biotechnology LLC (Luxa), a clinical-stage biotechnology company developing novel adult retinal pigment epithelial stem cell (RPESC) therapies for dry age-related macular degeneration (dry AMD), today announced the…
EyeMD EMR Healthcare Systems, Inc., a Leading Healthcare Technology Provider for Ophthalmologists, Announces Significant Growth Investment from Performant Capital
CHICAGO–(BUSINESS WIRE)–EyeMD EMR Healthcare Systems, Inc., (“EyeMD EMR” or “the Company”), a leading provider of healthcare technology software solutions purpose-built for ophthalmologists and eye care specialists, announced a significant majority g…